Advisory Services Network, LLC Eagle Pharmaceuticals, Inc. Transaction History

Advisory Services Network, LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 24, 2021	SELL	$40.32 - $50.97 $0 - $0	0 Closed	0 $0
Q4 2020 Feb 09, 2021	SELL	$41.72 - $51.34 $333 - $410	-8 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$37.02 - $51.28 $296 - $410	8 New	8 $0
Q4 2019 Feb 04, 2020	SELL	$54.32 - $64.31 $5,432 - $6,431	-100 Closed	0 $0
Q4 2018 Feb 15, 2019	SELL	$36.72 - $67.73 $1,836 - $3,386	-50 Reduced 33.33%	100 $4,000
Q3 2018 Nov 02, 2018	SELL	$66.65 - $83.86 $6,665 - $8,386	-100 Reduced 40.0%	150 $10,000
Q2 2018 Jul 27, 2018	SELL	$51.25 - $76.62 $56,375 - $84,282	-1,100 Reduced 81.48%	250 $20,000
Q1 2018 Apr 23, 2018	SELL	$52.16 - $66.86 $41,728 - $53,488	-800 Reduced 37.21%	1,350 $0
Q4 2017 Feb 08, 2018	SELL	$49.6 - $60.87 $586,520 - $719,787	-11,825 Reduced 84.62%	2,150 $115,000
Q3 2017 Oct 12, 2017	BUY	$46.62 - $60.36 $81,585 - $105,630	1,750 Added 14.31%	13,975 $833,000
Q2 2017 Aug 17, 2017	BUY	N/A	12,225	12,225 $964,000

8.59M

100

Ticker EGRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 13,015,900
Market Cap $12.5M
Description
Eagle Pharmaceuticals, Inc., a pharmaceutical company, focuses on developing and commercializing product candidates to treat diseases of the central nervous system or metabolic critical care, and oncology in the United States. The company offers Ryanodex for malignant hyperthermia; and Belrapzo and Bendeka for chronic lymphocytic leukemia and in...

Get notified when there are updates to the investment portfolio of Advisory Services Network, LLC, based on Form 13F filings with the SEC.

Stay updated on Advisory Services Network, LLC with notifications on news.